Serotonergic dysfunction precedes motor symptoms in PD; 5-HT1A/1B agonism proposed to reduce neuroinflammation. Despite high druggability, the mechanism lacks human causal validation and carries extensive clinical failure history including sarizotan, with no interventional evidence demonstrating cytokine modulation in CNS.
No linked papers recorded for this hypothesis yet.
No curated PDB or AlphaFold mapping for SLC6A4 yet. Search RCSB →
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for SLC6A4 (SERT), HTR1A, HTR1B.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
No resource usage or linked notebooks recorded for this hypothesis yet.